U.S. market Closed. Opens in 1 hour 18 minutes

SCPH | scPharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue13.59MN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue3.81M468.00K438.00K399.00K364.00KN/AN/AN/AN/A
Gross Profit9.78M-468.00K-438.00K-399.00K-364.00KN/AN/AN/AN/A
Operating Expenses65.18M36.16M25.82M29.93M32.91M29.67M23.44MN/AN/A
Selling, General & Admin53.37M20.62M9.78M11.78M8.27M13.72M9.11M6.05M2.58M
Research & Development11.81M15.53M16.04M18.15M24.63M15.95M14.33M11.86M8.27M
Other Operating Expenses3.60M1.42M315.00K-4.00K16.00K-56.00KN/AN/AN/A
Operating Income-55.40M-36.16M-25.82M-29.93M-32.91M-29.67M-23.44M-17.91M-10.84M
Other Expenses / Income586.00K-681.00K-2.21M-2.28M-91.00K-56.00K-381.00K-6.47M326.00K
Before Tax Income-54.81M-36.84M-28.03M-32.21M-33.00M-29.44M-23.82M-24.38M-10.52M
Income Tax Expenses458.11K681.00K2.45M2.18M1.42M-224.00KN/AN/AN/A
Net Income-54.81M-37.52M-30.49M-34.39M-34.41M-29.44M-23.82M-24.38M-10.52M
Interest Expenses8.12M3.30M2.58M2.59M1.77M1.43M797.00K6.51MN/A
Basic Shares Outstanding38.51M28.36M27.35M24.57M18.60M18.56M2.96M3.99M11.20M
Diluted Shares Outstanding38.51M28.36M27.35M24.57M18.60M18.56M2.96M3.99M11.20M
EBITDA-54.77M-33.54M-25.46M-29.62M-31.23M-28.01M-23.00M-17.86M-10.91M
EBITDA Margin-402.93%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-46.23M-33.54M-25.46M-29.62M-31.23M-28.23M-23.02M-17.86M-10.52M
EBIT Margin-340.09%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙